Biogen Plans to Shut Down Its Controversial Alzheimer ’ s Drug Aduhelm
Biogen will stop developing its Alzheimer’s treatment Aduhelm, a drug once seen as a potential blockbuster before stumbling soon after its launch a couple years ago.
The drugmaker said Wednesday that it will end a study of the drug needed for full approval from the Food and Drug Administration, and it will stop sales of Aduhelm.
[time-brightcove not-tgx=”true”]
Patients taking doses of Aduhelm available through the commercial market can continue until November. A company representative said there are about 2,500 people worldwide taking Aduhelm.
Biogen said it will turn its focus more to other tr...
Source: TIME: Health - January 31, 2024 Category: Consumer Health News Authors: Tom Murphy/AP Tags: Uncategorized healthscienceclimate wire Source Type: news
Biogen discontinues first Alzheimer's drug, goes all-in on Leqembi
Biogen is officially pivoting away from Aduhelm, the first Alzheimer's treatment the Cambridge drugmaker made. Biogen said over the past year it looked for potential partners or external financing for Aduhelm, but neither materialized. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 31, 2024 Category: Biotechnology Authors: Hannah Green Source Type: news
Neurimmune to regain global rights to brain amyloid depleter for the treatment of Alzheimer's disease
ZURICH, Switzerland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Neurimmune announced today that it regained global rights to aducanumab, a recombinant human antibody developed to deplete brain amyloid. Aducanumab was granted FDA accelerated approval for the treatment of Alzheimer's disease. Neurimmune…#zurich #switzerland #neurimmune #fda #biogen #ip #gmp #christophhock #brain #fabianbuller (Source: Reuters: Health)
Source: Reuters: Health - January 31, 2024 Category: Consumer Health News Source Type: news
Biogen Drops Alzheimer's Drug Aduhelm, Ending a 17-year Chapter Biogen Drops Alzheimer's Drug Aduhelm, Ending a 17-year Chapter
Biogen will end a post-approval study of Alzheimer ' s treatment Aduhelm and return the licensing rights on the drug after failing to find a partner to mitigate costs of...Reuters Health Information (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - January 31, 2024 Category: Psychiatry Tags: Neurology & Neurosurgery Source Type: news
GLP-1 Drugs Tame Brain Inflammation; Novel Painkiller Succeeds; Headache as Metaphor
(MedPage Today) -- Glucagon-like peptide 1 (GLP-1) receptor agonists that reduce obesity also dial down brain inflammation, leading researchers to investigate how these agents might help treat Alzheimer's or Parkinson's disease. (Nature)
IV ketamine... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - January 31, 2024 Category: Neurology Source Type: news
NIH panel to launch urgent investigation amid evidence Alzheimer's can SPREAD between people: Nearly 8,000 Americans received injection that can transmit memory-robbing condition
US scientists at the National Institutes of Health (NIH) are now preparing to 're-analyze' their data to detect a link to Alzheimer's in their patients. (Source: the Mail online | Health)
Source: the Mail online | Health - January 30, 2024 Category: Consumer Health News Source Type: news
No Moonshots With Paper Planes: Alzheimer ’s Trials Need Neurotech
Most Alzheimer's drug trials are using paper measurement tools developed in the 1980's and 1990's. Neurotechnology can do better for patients, while saving us billions. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 30, 2024 Category: Pharmaceuticals Authors: Naveen Rao, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news
Strategies Needed to Improve Delivery of Alzheimer Disease-Modifying Therapies
TUESDAY, Jan. 30, 2024 -- Strategies are needed to improve the delivery of Alzheimer disease (AD) disease-modifying therapies (DMTs), according to a report published online Jan. 30 by the RAND Corporation.
Jodi L. Liu, Ph.D., from the RAND... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 30, 2024 Category: Pharmaceuticals Source Type: news
Could FASTING protect you from Alzheimer's? Study suggests diet regime loved by Rishi Sunak could help
Cambridge University researchers studied around two dozen people, who only consumed water for 24 hours. Blood tests revealed a dramatic drop in their levels of inflammatory cells. (Source: the Mail online | Health)
Source: the Mail online | Health - January 30, 2024 Category: Consumer Health News Source Type: news
Will new CPT codes spark utilization of quantitative MRI?
Efforts to bring quantitative MRI analysis into clinical practice received a boost with the availability of two new Category III Current Procedural Terminology (CPT) codes for brain MRI.
Effective January 1, 2024, the new codes, 0865T and 0866T, support the use of software to analyze brain MRI exams with comparison to prior studies. AI software would qualify under the Category III CPT codes, which are for new and emerging technology:
0865T -- qMRI analysis of the brain with comparison to prior MR study(ies), including lesion identification, characterization, and quantification, with brain volume(s) quantification and/o...
Source: AuntMinnie.com Headlines - January 30, 2024 Category: Radiology Authors: Liz Carey Tags: Artificial Intelligence SENL Source Type: news
Alzheimer's May Be Transmissible in Rare Circumstances
(MedPage Today) -- Alzheimer's disease appeared to be transmissible under rare conditions, according to new research.
Five patients treated with human growth hormone from cadaveric pituitary glands when they were children subsequently developed... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - January 30, 2024 Category: Psychiatry Source Type: news
First Cases of Medically Acquired Alzheimer's Reported First Cases of Medically Acquired Alzheimer's Reported
Patients who received contaminated growth hormone developed AD decades later. The study suggests AD is transmissible, but researchers stress it cannot be transmitted through routine medical care.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - January 29, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news
Research in Context: Diagnosing dementia
This special Research in Context feature explores approaches to the diagnosis of Alzheimer ’s and other dementias and the development of strategies to try to prevent their progression. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - January 29, 2024 Category: Consumer Health News Source Type: news
Medicine stopped in 1980s linked to rare Alzheimer's cases
Contaminated injections of growth hormone may have caused five rare cases of dementia, scientists think. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 29, 2024 Category: Consumer Health News Source Type: news
Alzheimer's can be spread BETWEEN humans: Pioneering study reveals at least five people have 'caught' memory-robbing illness - as scientists warn hundreds more may be 'at risk'
Hormones, taken from dead donors between 1959 and 1985, were used to treat people with growth conditions in the UK before synthetic growth hormones were introduced. (Source: the Mail online | Health)
Source: the Mail online | Health - January 29, 2024 Category: Consumer Health News Source Type: news
